You are here

Organotypic Culture Models (OCM) developed from experimental animals for Chemical Toxicity Screening.

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43ES032363-01
Agency Tracking Number: R43ES032363
Amount: $252,129.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NIEHS
Solicitation Number: ES20-005
Timeline
Solicitation Year: 2020
Award Year: 2020
Award Start Date (Proposal Award Date): 2020-08-21
Award End Date (Contract End Date): 2021-07-31
Small Business Information
200 HOMER AVE STE 200
Ashland, MA 01721-1716
United States
DUNS: 147365936
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 SEYOUM AYEHUNIE
 (508) 881-6771
 sayehunie@mattek.com
Business Contact
 MITCHELL KLAUSNER
Phone: (508) 881-6771
Email: mklausner@mattek.com
Research Institution
N/A
Abstract

The demand for herbicides, insecticides, and fungicides will lead to increased production of new
chemicals by the agrochemical industry which may pose significant risk to human health. The
objective of this project is to develop novel, physiologically relevant animal cell based in
vitro organotypic culture models for screening chemicals such as pesticides. Such animal cell-
based models will narrow the gap in translational research by facilitating extrapolation of in vitro
findings to in vivo biological responses and ultimately will lead to reduced animal use.
The specific aims of the Phase 1 study are to: 1) Determine the maximum tolerated dose (MTD)
for 20 chemicals/pesticides using rat cell based organotypic airway and intestinal tissues, 2) utilize
a microphysiological perfused multiorgan on a chip (MOC) platform to assess the toxicity
response of a systemic organ (liver) and to further refine the MTD for these chemicals, 3) correlate
the in vitro MTD values with in vivo rat LD50 data and establish a hazard prediction model, and 4)
develop a 96-well tissue platform for high throughput chemical screening. During Phase 2, the
prediction model will be further tested and formally validated.
The development of animal cell based organotypic culture models for chemical screening aligns
with the strategic roadmap laid out by regulatory bodies to establish new approach methods
(NAM) that are efficient, predictive, and cost-effective alternatives to animal testing. The current
study is predicted to produce a toxicological platform which will: 1) predict chemical/pesticide
toxicity categories, 2) provide an easy-to-use, lower cost alternative to animal tests, and 3) reduce
the number of animals used in toxicological assays and meet the needs of regulatory bodies.The day-to-day human exposure to chemicals such as pesticides through contaminated food
drinking water, air pollution, and direct contact can impact human and animal health. In order to
reduce potential hazard, regulatory bodies are seeking the development of a better and efficient
chemical toxicity screening tools using animal-cell based in vitro organotypic culture model
(OCM) systems to replace or reduce current animal-based in vivo testing. During this project, we
will develop an in vitro assay method to screen pesticides from different classes and hazard levels
using three-dimensional rat-cell based (lung, intestine, and liver) based organotypic culture
models and a microphysiological platform.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government